Nurse Practitioner in Boswell, OK Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Amanda Lyn Vandenburg, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 415 6th Street, Boswell, OK 74727 Phone: 580-566-2530 Fax: 580-566-2533 |
Jodie H Moore, APRN-CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 415 6th St, Boswell, OK 74727 Phone: 580-566-2530 Fax: 580-566-2533 |
News Archive
Scientists reveal the mechanism of liquid-liquid phase separation of SARS-CoV-2 nucleocapsid
A team of scientists from the United States has recently revealed how interactions between the SARS-CoV-2 nucleocapsid protein and the double-stranded RNA motifs impart distinct droplet properties that can support multiple viral functions. The study is currently available on the bioRxiv* preprint server.
Analyzing properties of texture-modified foods for people with dysphagia
A piece of research by the UPV/EHU-University of the Basque Country is calling for an effort to bring various thickeners into line with standard guidelines, which would offer increased clinical safeguards.
New biomimetic culture system enables more extensive testing of drugs and gene therapies
Researchers at the University of Louisville have developed an easily reproducible system that enables them to keep slices of human hearts alive for a longer period of time, allowing more extensive testing of new drugs and gene therapies.
First-ever quality measures focus on treatment for older adults with hypoglycemia risk
The Endocrine Society and Avalere Health introduced the first-ever quality measures to help healthcare providers assess how well they identify and care for older adults at greater risk of hypoglycemia-low blood sugar that can be a dangerous complication of diabetes treatment.
Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015
Mirati Therapeutics, Inc. today presented data that demonstrated preliminary evidence of clinical activity from its investigational targeted tyrosine kinase inhibitor candidate, MGCD265, as part of the developmental therapeutics category at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago from May 29-June 2, 2015.
› Verified 2 days ago